Company name:
Teladoc Health Inc
-
IPO SHARE PRICE:$19.00
-
IPO DATE:July 01, 2015
-
TICKER:TDOC
-
MAIN STOCK EXCHANGE:New York Stock Exchange
-
CURRENT HQ LOCATION:2 Manhattanville Road Suite 203 Purchase New York 10577
-
FISCAL YEAR END:December 31
-
INCORPORATION JURISDICTION:DE
-
ORGANIZED AS THE FOLLOWING LEGAL TYPE:Corporation
-
Investor Relations Webpage:Coming soon!
-
TAX RATE:USA federal corporate nominal income tax rate is 21%
Short Description
Teladoc Health Inc
We are working hard and as soon as possible to provide company description soon. Feel free to reach out to request it sooner: improve@real-clear-investing.com
Income Statement
(USD in thousand)
Selected Quarter:
31-Dec
2020
2020
Revenue
Gross receipts in the form of cash (great!) and promises to pay (Account Receivables - not so great as some of them will never be collected but reality of business!) from all its customers
Selected Quarter:
31-Dec
2020
2020
Operating expenses
Cost (labor, materials, depreciation, overhead, etc) for delivering service or manufacturing a product that business sells
219.6%
89.1% —
General and administrative
32.1% —
Cost of revenue excluding depreciation and amortization
24.5% —
Sales
24.5% —
Marketing and advertising
24.2% —
Product technology and development
15.0% —
Acquisition and integration related costs
9.6% —
Depreciation and amortization
0.7% —
Legal and regulatory expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cost of revenue
|
44,677 | - | 42,799 | - | - | - | - | - | - | - | ||||||||||||||||
|
Cost of revenue excluding depreciation and amortization
Cost of revenue excluding depreciation and amortization
|
44,677 | 41,634 | 42,799 | 55,355 | 72,382 | 90,780 | 104,725 | 122,942 | 390,829 | 491,768 | ||||||||||||||||
|
Sales
|
16,212 | 15,832 | 16,120 | 16,751 | 17,940 | 18,687 | 23,483 | 93,942 | 154,052 | 375,768 | ||||||||||||||||
|
Gross profit
|
83,896 | - | - | - | - | - | - | - | - | - | ||||||||||||||||
|
Marketing and advertising
|
26,404 | 26,616 | 31,321 | 25,356 | 32,515 | 47,578 | 52,302 | 93,751 | 226,146 | 375,004 | ||||||||||||||||
|
Product technology and development
|
15,987 | 16,665 | 15,746 | 16,246 | 19,257 | 23,029 | 29,958 | 92,697 | 164,941 | 370,788 | ||||||||||||||||
|
General and administrative
|
35,982 | 38,549 | 38,681 | 44,482 | 45,120 | 54,383 | 56,930 | 341,375 | 497,808 | 1,365,500 | ||||||||||||||||
|
Legal and regulatory expenses
|
1,586 | 2,019 | 1,634 | 1,523 | 1,222 | 2,232 | 2,812 | 2,610 | 8,876 | 10,440 | ||||||||||||||||
|
Acquisition and integration related costs
|
1,012 | 1,136 | 1,995 | 2,477 | 3,664 | 1,627 | 25,395 | 57,550 | 88,236 | 230,200 | ||||||||||||||||
|
Acquisition-related costs
|
- | - | - | - | - | - | - | - | - | - | ||||||||||||||||
|
Depreciation and amortization
|
9,600 | 9,848 | 9,617 | 9,887 | 9,710 | 9,893 | 12,932 | 36,960 | 69,495 | 147,840 | ||||||||||||||||
|
Gain on sale
|
- | - | - | - | - | - | - | - | - | - | ||||||||||||||||
|
Total operating expenses
|
151,460 | - | - | - | - | - | - | - | - | - | ||||||||||||||||
|
Total expenses
|
151,460 | 152,299 | 157,913 | 172,077 | 201,810 | 248,209 | 308,537 | 841,827 | 1,600,383 | 3,367,308 |
Selected Quarter:
31-Dec
2020
2020
Operating Income
Income after excluding Operating Expenses from Total Revenue
119.6%
119.6% —
Operating Income
Key metric that shows earnings potential of the company's business model
Selected Quarter:
31-Dec
2020
2020
Non-operating expenses
Cost usually unrelated to delivering service or manufacturing a product that business sells
0.0%
0.0% —
Loss on early repayment of debt
Selected Quarter:
31-Dec
2020
2020
Earnings before Interest and Taxes (EBIT)
Income after excluding Operating and Non-operating Expenses from Total Revenue
119.6%
119.6% —
EBIT
Another income metric but unlike Operating Income it is closer to the ultimate income metric - Net Income by removing expenses that are not related to earning Revenue as they are supposed to be accidental and transitory
Selected Quarter:
31-Dec
2020
2020
Interest Expense and Income, Taxes
Expenses driven mostly by company management's choices, nature of business (capital intensive vs not) about financing (debt vs equity) and legal structure
16.9%
22.3% —
Income tax expense or benefit
5.4% —
Interest expense
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Interest expense (income)
|
- | - | - | - | - | - | - | - | - | - | ||||||||||||||||
|
Interest expense
|
6,521 | 7,211 | 7,700 | 7,581 | 9,303 | 13,151 | 17,222 | 20,819 | 60,495 | 83,276 | ||||||||||||||||
|
Income before income taxes
|
(29,408) | (29,234) | (27,644) | (23,169) | (30,314) | (28,081) | (38,174) | (479,424) | (575,993) | (1,917,696) | ||||||||||||||||
|
Income tax expense or benefit
|
742 | 90 | (7,298) | (4,125) | (711) | (2,399) | (2,290) | (85,457) | (90,857) | (341,828) |
Selected Quarter:
31-Dec
2020
2020
Net income (loss)
Ultimate measure of Income - Net result after excluding all expenses from Total Revenue
102.8%
102.8% —
Net income (loss)
It is a residue that is left from Total Revenue after paying all kind of expenses and belongs to all equity holders in the company. Some of these shareholders such Non-controlling interest or Preferred equity gets their share before Common shareholders
Basic Shares Outstanding
Basic shares outstanding as of certain dates reported by Company on its annual and quarterly filings, these numbers are NOT used calculation of basic EPS. They help to see share issuance by company in perspective
Selected Quarter:
31-Dec
2020
2020
EPS
Net Income / Shares Outstanding = EPS before dilution or Basic EPS; Net Income/ ( Shares Outstanding + potentially available shares from conversion of various option instruments)